| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.43B | 31.21B | 25.97B | 21.63B | 21.93B | 22.66B |
| Gross Profit | 5.96B | 7.69B | 6.07B | 4.36B | 4.25B | 4.35B |
| EBITDA | 1.51B | 2.22B | 1.57B | 816.00M | 557.00M | 302.00M |
| Net Income | 21.00M | 1.23B | 427.00M | 367.00M | 273.00M | 39.00M |
Balance Sheet | ||||||
| Total Assets | 25.09B | 30.75B | 26.05B | 24.14B | 21.20B | 21.75B |
| Cash, Cash Equivalents and Short-Term Investments | 9.22B | 5.80B | 4.68B | 1.97B | 3.59B | 5.50B |
| Total Debt | 0.00 | 3.50B | 1.98B | 1.50B | 0.00 | 0.00 |
| Total Liabilities | 15.67B | 19.02B | 15.87B | 14.15B | 11.48B | 12.01B |
| Stockholders Equity | 9.42B | 11.73B | 10.18B | 9.99B | 9.71B | 9.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 990.00M | 2.69B | -2.27B | -807.00M | 1.36B |
| Operating Cash Flow | 0.00 | 1.17B | 2.85B | -2.04B | -593.00M | 1.63B |
| Investing Cash Flow | 0.00 | -1.33B | -464.00M | -845.00M | -1.03B | -247.00M |
| Financing Cash Flow | 0.00 | 1.27B | 198.00M | 1.26B | -269.00M | -769.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥201.22B | 22.33 | 11.00% | 2.20% | 6.75% | -0.16% | |
73 Outperform | ¥25.83B | 8.53 | ― | 2.62% | -14.20% | 231.20% | |
72 Outperform | ¥421.05B | 24.29 | ― | 1.30% | 9.57% | 9.73% | |
68 Neutral | ¥46.76B | 3.75 | ― | 1.94% | 15.35% | 10.88% | |
67 Neutral | ¥7.36B | 57.57 | ― | 1.36% | -4.59% | -14.60% | |
64 Neutral | ¥17.24B | 14.00 | ― | 1.79% | 20.19% | 186.76% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |